These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10898699)

  • 1. Impact of n-6 polyunsaturated fatty acids on growth of multidrug-resistant Pseudomonas aeruginosa: interactions with amikacin and ceftazidime.
    Giamarellos-Bourboulis EJ; Grecka P; Dionyssiou-Asteriou A; Giamarellou H
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2187-9. PubMed ID: 10898699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Giamarellos-Bourboulis EJ; Grecka P; Dionyssiou-Asteriou A; Giamarellou H
    Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):283-7. PubMed ID: 9654401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Plachouras D; Skiathitis S; Raftogiannis M; Dionyssiou-Asteriou A; Dontas I; Karayannacos PE; Giamarellou H
    J Antimicrob Chemother; 2003 Feb; 51(2):423-6. PubMed ID: 12562715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Mouktaroudi M; Adamis T; Koussoulas V; Baziaka F; Perrea D; Karayannacos PE; Giamarellou H
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
    Tessier F; Quentin C
    Eur J Clin Microbiol Infect Dis; 1997 Feb; 16(2):159-62. PubMed ID: 9105845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro interactions of ceftazidime, meropenem, and imipenem with amikacin on multiresistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    Diagn Microbiol Infect Dis; 1997 Oct; 29(2):81-6. PubMed ID: 9368083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro bactericidal activity between cefepime and ceftazidime, alone and associated with amikacin, against carbapenem-resistant Pseudomonas aeruginosa strains.
    Bantar C; Di Chiara M; Nicola F; Relloso S; Smayevsky J
    Diagn Microbiol Infect Dis; 2000 May; 37(1):41-4. PubMed ID: 10794939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postantibiotic effect of antimicrobial combinations on multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Kentepozidis N; Antonopoulou A; Plachouras D; Tsaganos T; Giamarellou H
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):113-7. PubMed ID: 15698716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activities of various antibiotics, alone and in combination with amikacin against Pseudomonas aeruginosa.
    Gerçeker AA; Gürler B
    J Antimicrob Chemother; 1995 Oct; 36(4):707-11. PubMed ID: 8591946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
    Sood P; Mandal A; Mishra B
    Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effects of a combination of antipseudomonal antibiotics against multi-drug resistant Pseudomonas aeruginosa.
    Oie S; Sawa A; Kamiya A; Mizuno H
    J Antimicrob Chemother; 1999 Nov; 44(5):689-91. PubMed ID: 10552987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States.
    Sader HS; Huband MD; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Van Laethem Y; Lagast H; Klastersky J
    Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
    Mayer I; Nagy E
    J Antimicrob Chemother; 1999 May; 43(5):651-7. PubMed ID: 10382886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
    Valdes JM; Baltch AL; Smith RP; Hammer MC; Ritz WJ
    J Antimicrob Chemother; 1990 Apr; 25(4):575-84. PubMed ID: 2112539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of Cefiderocol and Comparators against Isolates from Cancer Patients.
    Rolston KVI; Gerges B; Shelburne S; Aitken SL; Raad I; Prince RA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.